Taiwan · Delayed Price · Currency is TWD General Biologicals Statistics
Total Valuation
TPEX:4117 has a market cap or net worth of TWD 743.66 million. The enterprise value is 2.61 billion.
| Market Cap | 743.66M |
| Enterprise Value | 2.61B |
Important Dates
The next estimated earnings date is Wednesday, August 12, 2026.
| Earnings Date | Aug 12, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
TPEX:4117 has 70.83 million shares outstanding. The number of shares has increased by 4.62% in one year.
| Current Share Class | 70.83M |
| Shares Outstanding | 70.83M |
| Shares Change (YoY) | +4.62% |
| Shares Change (QoQ) | +9.25% |
| Owned by Insiders (%) | 8.12% |
| Owned by Institutions (%) | 1.41% |
| Float | 45.25M |
Valuation Ratios
The trailing PE ratio is 1.41.
| PE Ratio | 1.41 |
| Forward PE | n/a |
| PS Ratio | 3.45 |
| PB Ratio | 0.85 |
| P/TBV Ratio | 0.91 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | 5.60 |
| EV / Sales | 12.08 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 2.00, with a Debt / Equity ratio of 2.86.
| Current Ratio | 2.00 |
| Quick Ratio | 1.78 |
| Debt / Equity | 2.86 |
| Debt / EBITDA | n/a |
| Debt / FCF | -8.12 |
| Interest Coverage | -4.72 |
Financial Efficiency
Return on equity (ROE) is 80.22% and return on invested capital (ROIC) is -6.63%.
| Return on Equity (ROE) | 80.22% |
| Return on Assets (ROA) | -2.95% |
| Return on Invested Capital (ROIC) | -6.63% |
| Return on Capital Employed (ROCE) | -4.41% |
| Weighted Average Cost of Capital (WACC) | 2.94% |
| Revenue Per Employee | 2.66M |
| Profits Per Employee | 5.75M |
| Employee Count | 81 |
| Asset Turnover | 0.05 |
| Inventory Turnover | 2.69 |
Taxes
In the past 12 months, TPEX:4117 has paid 40.67 million in taxes.
| Income Tax | 40.67M |
| Effective Tax Rate | 8.05% |
Stock Price Statistics
The stock price has decreased by -30.94% in the last 52 weeks. The beta is 0.61, so TPEX:4117's price volatility has been lower than the market average.
| Beta (5Y) | 0.61 |
| 52-Week Price Change | -30.94% |
| 50-Day Moving Average | 11.31 |
| 200-Day Moving Average | 14.04 |
| Relative Strength Index (RSI) | 47.87 |
| Average Volume (20 Days) | 793,591 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, TPEX:4117 had revenue of TWD 215.74 million and earned 465.84 million in profits. Earnings per share was 7.44.
| Revenue | 215.74M |
| Gross Profit | 59.62M |
| Operating Income | -197.05M |
| Pretax Income | 505.51M |
| Net Income | 465.84M |
| EBITDA | -131.23M |
| EBIT | -197.05M |
| Earnings Per Share (EPS) | 7.44 |
Balance Sheet
The company has 634.75 million in cash and 2.50 billion in debt, with a net cash position of -1.86 billion or -26.28 per share.
| Cash & Cash Equivalents | 634.75M |
| Total Debt | 2.50B |
| Net Cash | -1.86B |
| Net Cash Per Share | -26.28 |
| Equity (Book Value) | 872.47M |
| Book Value Per Share | 12.29 |
| Working Capital | 395.62M |
Cash Flow
In the last 12 months, operating cash flow was -127.26 million and capital expenditures -180.02 million, giving a free cash flow of -307.28 million.
| Operating Cash Flow | -127.26M |
| Capital Expenditures | -180.02M |
| Depreciation & Amortization | 65.82M |
| Net Borrowing | 168.11M |
| Free Cash Flow | -307.28M |
| FCF Per Share | -4.34 |
Margins
Gross margin is 27.63%, with operating and profit margins of -91.34% and 215.93%.
| Gross Margin | 27.63% |
| Operating Margin | -91.34% |
| Pretax Margin | 234.31% |
| Profit Margin | 215.93% |
| EBITDA Margin | -60.83% |
| EBIT Margin | -91.34% |
| FCF Margin | n/a |
Dividends & Yields
TPEX:4117 does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -4.62% |
| Shareholder Yield | -4.62% |
| Earnings Yield | 62.64% |
| FCF Yield | -41.32% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | |
| Lynch Upside | |
| Graham Number | |
| Graham Upside |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
TPEX:4117 has an Altman Z-Score of 0.17 and a Piotroski F-Score of 3. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | 0.17 |
| Piotroski F-Score | 3 |